Mesirow Financial Investment Management - Fixed Income’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,872
Closed -$285K 242
2016
Q2
$285K Sell
3,872
-55
-1% -$3.89K 0.02% 188
2016
Q1
$251K Hold
3,927
0.12% 156
2015
Q4
$270K Hold
3,927
0.12% 156
2015
Q3
$232K Hold
3,927
0.06% 156
2015
Q2
$261K Hold
3,927
0.06% 162
2015
Q1
$253K Hold
3,927
0.06% 155
2014
Q4
$232K Hold
3,927
0.06% 170
2014
Q3
$201K Buy
+3,927
New +$196K 0.05% 168
2014
Q2
Sell
-3,927
Closed -$204K 186
2014
Q1
$204K Sell
3,927
-11,303
-74% -$601K 0.05% 174
2013
Q4
$809K Hold
15,230
0.22% 119
2013
Q3
$705K Buy
+15,230
New +$669K 0.2% 117

Other funds holding BMY

Mesirow Financial Investment Management - Fixed Income's BMY Position: Q3 2016 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 3,872 shares — an estimated $285K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in BMY in Q3 2013 and held it in 11 quarters. The position peaked at $809K in Q4 2013. 1,523 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 3,872 Bristol-Myers Squibb shares in Q3 2016, an estimated $285K.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 11 quarters.
  • Mesirow Financial Investment Management - Fixed Income's Bristol-Myers Squibb position peaked at $809K in Q4 2013.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2016, filed 28 Oct 2016.